Neximmune Inc NEXI:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
18.69quote price arrow down-1.31 (-6.55%)
Volume
456,047
52 week range
17.06 - 28.00

...

Loading . . .

KEY STATS

  • Open20.45
  • Day High21.04
  • Day Low18.03
  • Prev Close20.00
  • 52 Week High28.00
  • 52 Week High Date02/12/21
  • 52 Week Low17.06
  • 52 Week Low Date03/04/21
  • Market Cap402.77M
  • Shares Out21.55M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.53
  • P/E (TTM)-12.25
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-25.389M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-105.50%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Neximmune Inc News

There is no recent news for this security.

Latest NEXI News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
NexImmune, Inc is a clinical-stage biotechnology company. The Company is engaged in developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. The Company provides Artificial Immune Modulation (AIM) which is a nanoparticle technology platform. Its AIM technology enables it to construct nanoparticles that function as synthetic dendritic cells capable of directing a specific T cell-mediated...
Kenneth Carter Ph.D.
Chairman
Alain Cappeluti CPA
Chief Financial Officer
Bruce McCreedy Jr., Ph.D.
Executive Vice President
Address
9119 GAITHER ROAD
Gaithersburg, MD
20878
United States